Logo image of SHR.DE

SCHINDLER HOLDING AG-REG (SHR.DE) Stock Fundamental Analysis

Europe - FRA:SHR - CH0024638212 - Common Stock

304.5 EUR
0 (0%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, SHR scores 6 out of 10 in our fundamental rating. SHR was compared to 102 industry peers in the Machinery industry. SHR gets an excellent profitability rating and is at the same time showing great financial health properties. SHR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

SHR had positive earnings in the past year.
In the past year SHR had a positive cash flow from operations.
SHR had positive earnings in each of the past 5 years.
In the past 5 years SHR always reported a positive cash flow from operatings.
SHR.DE Yearly Net Income VS EBIT VS OCF VS FCFSHR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

SHR's Return On Assets of 8.71% is amongst the best of the industry. SHR outperforms 86.27% of its industry peers.
The Return On Equity of SHR (21.42%) is better than 89.22% of its industry peers.
SHR's Return On Invested Capital of 18.09% is amongst the best of the industry. SHR outperforms 93.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SHR is significantly above the industry average of 8.70%.
The 3 year average ROIC (14.96%) for SHR is below the current ROIC(18.09%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.71%
ROE 21.42%
ROIC 18.09%
ROA(3y)6.91%
ROA(5y)6.86%
ROE(3y)17.36%
ROE(5y)17.97%
ROIC(3y)14.96%
ROIC(5y)14.99%
SHR.DE Yearly ROA, ROE, ROICSHR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of SHR (8.87%) is better than 82.35% of its industry peers.
In the last couple of years the Profit Margin of SHR has grown nicely.
SHR's Operating Margin of 11.89% is fine compared to the rest of the industry. SHR outperforms 79.41% of its industry peers.
SHR's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 34.91%, SHR is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SHR has remained more or less at the same level.
Industry RankSector Rank
OM 11.89%
PM (TTM) 8.87%
GM 34.91%
OM growth 3Y2.48%
OM growth 5Y0.14%
PM growth 3Y4.69%
PM growth 5Y2%
GM growth 3Y1.62%
GM growth 5Y0.44%
SHR.DE Yearly Profit, Operating, Gross MarginsSHR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SHR is creating value.
The number of shares outstanding for SHR has been reduced compared to 1 year ago.
The number of shares outstanding for SHR has been reduced compared to 5 years ago.
Compared to 1 year ago, SHR has a worse debt to assets ratio.
SHR.DE Yearly Shares OutstandingSHR.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SHR.DE Yearly Total Debt VS Total AssetsSHR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 5.04 indicates that SHR is not in any danger for bankruptcy at the moment.
SHR has a better Altman-Z score (5.04) than 91.18% of its industry peers.
The Debt to FCF ratio of SHR is 0.46, which is an excellent value as it means it would take SHR, only 0.46 years of fcf income to pay off all of its debts.
SHR's Debt to FCF ratio of 0.46 is amongst the best of the industry. SHR outperforms 92.16% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that SHR is not too dependend on debt financing.
SHR has a Debt to Equity ratio of 0.10. This is amongst the best in the industry. SHR outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.46
Altman-Z 5.04
ROIC/WACC3.63
WACC4.98%
SHR.DE Yearly LT Debt VS Equity VS FCFSHR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

SHR has a Current Ratio of 1.39. This is a normal value and indicates that SHR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SHR (1.39) is comparable to the rest of the industry.
SHR has a Quick Ratio of 1.21. This is a normal value and indicates that SHR is financially healthy and should not expect problems in meeting its short term obligations.
SHR has a Quick ratio of 1.21. This is in the better half of the industry: SHR outperforms 65.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.21
SHR.DE Yearly Current Assets VS Current LiabilitesSHR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

SHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.96%, which is quite good.
SHR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.85% yearly.
Looking at the last year, SHR shows a decrease in Revenue. The Revenue has decreased by -2.07% in the last year.
SHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.06% yearly.
EPS 1Y (TTM)8.96%
EPS 3Y3.35%
EPS 5Y1.85%
EPS Q2Q%11.34%
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y0%
Revenue growth 5Y-0.06%
Sales Q2Q%-50.74%

3.2 Future

SHR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.80% yearly.
SHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.28% yearly.
EPS Next Y7.44%
EPS Next 2Y7.93%
EPS Next 3Y7.87%
EPS Next 5Y6.8%
Revenue Next Year-2.2%
Revenue Next 2Y0.54%
Revenue Next 3Y1.75%
Revenue Next 5Y3.28%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SHR.DE Yearly Revenue VS EstimatesSHR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
SHR.DE Yearly EPS VS EstimatesSHR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.46 indicates a quite expensive valuation of SHR.
SHR's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of SHR to the average of the S&P500 Index (27.90), we can say SHR is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 26.01, the valuation of SHR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SHR indicates a slightly more expensive valuation: SHR is more expensive than 71.57% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.36. SHR is around the same levels.
Industry RankSector Rank
PE 28.46
Fwd PE 26.01
SHR.DE Price Earnings VS Forward Price EarningsSHR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

72.55% of the companies in the same industry are cheaper than SHR, based on the Enterprise Value to EBITDA ratio.
SHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 20.13
EV/EBITDA 18.95
SHR.DE Per share dataSHR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.82
PEG (5Y)15.38
EPS Next 2Y7.93%
EPS Next 3Y7.87%

4

5. Dividend

5.1 Amount

SHR has a Yearly Dividend Yield of 2.00%.
SHR's Dividend Yield is a higher than the industry average which is at 2.40.
Compared to an average S&P500 Dividend Yield of 2.44, SHR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2%

5.2 History

The dividend of SHR has a limited annual growth rate of 4.60%.
Dividend Growth(5Y)4.6%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

SHR pays out 65.15% of its income as dividend. This is not a sustainable payout ratio.
The dividend of SHR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP65.15%
EPS Next 2Y7.93%
EPS Next 3Y7.87%
SHR.DE Yearly Income VS Free CF VS DividendSHR.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
SHR.DE Dividend Payout.SHR.DE Dividend Payout, showing the Payout Ratio.SHR.DE Dividend Payout.PayoutRetained Earnings

SCHINDLER HOLDING AG-REG

FRA:SHR (10/6/2025, 7:00:00 PM)

304.5

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-18 2025-07-18/bmo
Earnings (Next)10-24 2025-10-24
Inst Owners45.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.82B
Analysts72
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2%
Yearly Dividend5.36
Dividend Growth(5Y)4.6%
DP65.15%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.96%
Min EPS beat(2)2.96%
Max EPS beat(2)14.96%
EPS beat(4)4
Avg EPS beat(4)16.06%
Min EPS beat(4)2.96%
Max EPS beat(4)32.54%
EPS beat(8)8
Avg EPS beat(8)16.81%
EPS beat(12)12
Avg EPS beat(12)21.82%
EPS beat(16)15
Avg EPS beat(16)20.06%
Revenue beat(2)2
Avg Revenue beat(2)1%
Min Revenue beat(2)0.18%
Max Revenue beat(2)1.81%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)79.2%
EPS NQ rev (3m)79.2%
EPS NY rev (1m)0.23%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-1.56%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-2.93%
Valuation
Industry RankSector Rank
PE 28.46
Fwd PE 26.01
P/S 2.75
P/FCF 20.13
P/OCF 18.85
P/B 6.63
P/tB 9.62
EV/EBITDA 18.95
EPS(TTM)10.7
EY3.51%
EPS(NY)11.71
Fwd EY3.84%
FCF(TTM)15.13
FCFY4.97%
OCF(TTM)16.16
OCFY5.31%
SpS110.86
BVpS45.9
TBVpS31.65
PEG (NY)3.82
PEG (5Y)15.38
Profitability
Industry RankSector Rank
ROA 8.71%
ROE 21.42%
ROCE 22.76%
ROIC 18.09%
ROICexc 18.09%
ROICexgc 23.99%
OM 11.89%
PM (TTM) 8.87%
GM 34.91%
FCFM 13.65%
ROA(3y)6.91%
ROA(5y)6.86%
ROE(3y)17.36%
ROE(5y)17.97%
ROIC(3y)14.96%
ROIC(5y)14.99%
ROICexc(3y)41.07%
ROICexc(5y)40.5%
ROICexgc(3y)123.39%
ROICexgc(5y)114.34%
ROCE(3y)18.87%
ROCE(5y)18.94%
ROICexcg growth 3Y10.08%
ROICexcg growth 5Y16.08%
ROICexc growth 3Y4.66%
ROICexc growth 5Y4.57%
OM growth 3Y2.48%
OM growth 5Y0.14%
PM growth 3Y4.69%
PM growth 5Y2%
GM growth 3Y1.62%
GM growth 5Y0.44%
F-Score8
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.46
Debt/EBITDA 0.28
Cap/Depr 31.5%
Cap/Sales 0.93%
Interest Coverage 42.68
Cash Conversion 98.3%
Profit Quality 153.9%
Current Ratio 1.39
Quick Ratio 1.21
Altman-Z 5.04
F-Score8
WACC4.98%
ROIC/WACC3.63
Cap/Depr(3y)33.35%
Cap/Depr(5y)35.4%
Cap/Sales(3y)1%
Cap/Sales(5y)1.1%
Profit Quality(3y)127.63%
Profit Quality(5y)145.02%
High Growth Momentum
Growth
EPS 1Y (TTM)8.96%
EPS 3Y3.35%
EPS 5Y1.85%
EPS Q2Q%11.34%
EPS Next Y7.44%
EPS Next 2Y7.93%
EPS Next 3Y7.87%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y0%
Revenue growth 5Y-0.06%
Sales Q2Q%-50.74%
Revenue Next Year-2.2%
Revenue Next 2Y0.54%
Revenue Next 3Y1.75%
Revenue Next 5Y3.28%
EBIT growth 1Y9.88%
EBIT growth 3Y2.48%
EBIT growth 5Y0.08%
EBIT Next Year29.68%
EBIT Next 3Y14%
EBIT Next 5Y11.18%
FCF growth 1Y27.12%
FCF growth 3Y7.93%
FCF growth 5Y10.26%
OCF growth 1Y25.49%
OCF growth 3Y6.67%
OCF growth 5Y6.12%